Loading…
Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure
Dysregulation of autonomic nervous system activity can trigger ventricular arrhythmias and sudden death in patients with heart failure. N-type Ca(2+) channels (NCCs) play an important role in sympathetic nervous system activation by regulating the calcium entry that triggers release of neurotransmit...
Saved in:
Published in: | Cardiovascular research 2014-10, Vol.104 (1), p.183-193 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c253t-879507e71335f7ae02b325fa42bb7ae162eba9b63a65b049307b0489f2d6d5e73 |
---|---|
cites | cdi_FETCH-LOGICAL-c253t-879507e71335f7ae02b325fa42bb7ae162eba9b63a65b049307b0489f2d6d5e73 |
container_end_page | 193 |
container_issue | 1 |
container_start_page | 183 |
container_title | Cardiovascular research |
container_volume | 104 |
creator | Yamada, Yuko Kinoshita, Hideyuki Kuwahara, Koichiro Nakagawa, Yasuaki Kuwabara, Yoshihiro Minami, Takeya Yamada, Chinatsu Shibata, Junko Nakao, Kazuhiro Cho, Kosai Arai, Yuji Yasuno, Shinji Nishikimi, Toshio Ueshima, Kenji Kamakura, Shiro Nishida, Motohiro Kiyonaka, Shigeki Mori, Yasuo Kimura, Takeshi Kangawa, Kenji Nakao, Kazuwa |
description | Dysregulation of autonomic nervous system activity can trigger ventricular arrhythmias and sudden death in patients with heart failure. N-type Ca(2+) channels (NCCs) play an important role in sympathetic nervous system activation by regulating the calcium entry that triggers release of neurotransmitters from peripheral sympathetic nerve terminals. We have investigated the ability of NCC blockade to prevent lethal arrhythmias associated with heart failure.
We compared the effects of cilnidipine, a dual N- and L-type Ca(2+) channel blocker, with those of nitrendipine, a selective L-type Ca(2+) channel blocker, in transgenic mice expressing a cardiac-specific, dominant-negative form of neuron-restrictive silencer factor (dnNRSF-Tg). In this mouse model of dilated cardiomyopathy leading to sudden arrhythmic death, cardiac structure and function did not significantly differ among the control, cilnidipine, and nitrendipine groups. However, cilnidipine dramatically reduced arrhythmias in dnNRSF-Tg mice, significantly improving their survival rate and correcting the imbalance between cardiac sympathetic and parasympathetic nervous system activity. A β-blocker, bisoprolol, showed similar effects in these mice. Genetic titration of NCCs, achieved by crossing dnNRSF-Tg mice with mice lacking CACNA1B, which encodes the α1 subunit of NCCs, improved the survival rate. With restoration of cardiac autonomic balance, dnNRSF-Tg;CACNA1B(+/-) mice showed fewer malignant arrhythmias than dnNRSF-Tg;CACNA1B(+/+) mice.
Both pharmacological blockade of NCCs and their genetic titration improved cardiac autonomic balance and prevented lethal arrhythmias in a mouse model of dilated cardiomyopathy and sudden arrhythmic death. Our findings suggest that NCC blockade is a potentially useful approach to preventing sudden death in patients with heart failure. |
doi_str_mv | 10.1093/cvr/cvu185 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1566112286</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1566112286</sourcerecordid><originalsourceid>FETCH-LOGICAL-c253t-879507e71335f7ae02b325fa42bb7ae162eba9b63a65b049307b0489f2d6d5e73</originalsourceid><addsrcrecordid>eNo9UcuO1DAQtBCInV248AGojwgU8GNsJ0c04rHSCi5wjtpORzFKnMF2Bs2v8LV4NcseWtUlVZXUXYy9Evy94J364E-pziZa_YTthNW6UXKvn7Id57xtjDLqil3n_KtSre3-ObuSWnBujd2xv7dxCi6UsEZYR_jWlPOR4IDyHfgJY6Q5Ay40hzVhobpHCIvDGaMnCBE8piGgB9zKGtcleIiUTgToSziFcq6GAY6JThRLhpnKhDNgStO5TEvAfJ9RXQR_QplgIkwFRgzzlugFezbinOnlA96wn58__Th8be6-f7k9fLxrvNSqNK3tNLdkhVJ6tEhcOiX1iHvpXKXCSHLYOaPQaMf3neK2QtuNcjCDJqtu2JtL7jGtvzfKpV9C9jTXG2ndci-0MUJI2ZoqfXuR-rTmnGjsjyksmM694P19F33tor90UcWvH3I3t9DwKP3_fPUPG06IRQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1566112286</pqid></control><display><type>article</type><title>Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure</title><source>Oxford Journals Online</source><creator>Yamada, Yuko ; Kinoshita, Hideyuki ; Kuwahara, Koichiro ; Nakagawa, Yasuaki ; Kuwabara, Yoshihiro ; Minami, Takeya ; Yamada, Chinatsu ; Shibata, Junko ; Nakao, Kazuhiro ; Cho, Kosai ; Arai, Yuji ; Yasuno, Shinji ; Nishikimi, Toshio ; Ueshima, Kenji ; Kamakura, Shiro ; Nishida, Motohiro ; Kiyonaka, Shigeki ; Mori, Yasuo ; Kimura, Takeshi ; Kangawa, Kenji ; Nakao, Kazuwa</creator><creatorcontrib>Yamada, Yuko ; Kinoshita, Hideyuki ; Kuwahara, Koichiro ; Nakagawa, Yasuaki ; Kuwabara, Yoshihiro ; Minami, Takeya ; Yamada, Chinatsu ; Shibata, Junko ; Nakao, Kazuhiro ; Cho, Kosai ; Arai, Yuji ; Yasuno, Shinji ; Nishikimi, Toshio ; Ueshima, Kenji ; Kamakura, Shiro ; Nishida, Motohiro ; Kiyonaka, Shigeki ; Mori, Yasuo ; Kimura, Takeshi ; Kangawa, Kenji ; Nakao, Kazuwa</creatorcontrib><description>Dysregulation of autonomic nervous system activity can trigger ventricular arrhythmias and sudden death in patients with heart failure. N-type Ca(2+) channels (NCCs) play an important role in sympathetic nervous system activation by regulating the calcium entry that triggers release of neurotransmitters from peripheral sympathetic nerve terminals. We have investigated the ability of NCC blockade to prevent lethal arrhythmias associated with heart failure.
We compared the effects of cilnidipine, a dual N- and L-type Ca(2+) channel blocker, with those of nitrendipine, a selective L-type Ca(2+) channel blocker, in transgenic mice expressing a cardiac-specific, dominant-negative form of neuron-restrictive silencer factor (dnNRSF-Tg). In this mouse model of dilated cardiomyopathy leading to sudden arrhythmic death, cardiac structure and function did not significantly differ among the control, cilnidipine, and nitrendipine groups. However, cilnidipine dramatically reduced arrhythmias in dnNRSF-Tg mice, significantly improving their survival rate and correcting the imbalance between cardiac sympathetic and parasympathetic nervous system activity. A β-blocker, bisoprolol, showed similar effects in these mice. Genetic titration of NCCs, achieved by crossing dnNRSF-Tg mice with mice lacking CACNA1B, which encodes the α1 subunit of NCCs, improved the survival rate. With restoration of cardiac autonomic balance, dnNRSF-Tg;CACNA1B(+/-) mice showed fewer malignant arrhythmias than dnNRSF-Tg;CACNA1B(+/+) mice.
Both pharmacological blockade of NCCs and their genetic titration improved cardiac autonomic balance and prevented lethal arrhythmias in a mouse model of dilated cardiomyopathy and sudden arrhythmic death. Our findings suggest that NCC blockade is a potentially useful approach to preventing sudden death in patients with heart failure.</description><identifier>ISSN: 0008-6363</identifier><identifier>EISSN: 1755-3245</identifier><identifier>DOI: 10.1093/cvr/cvu185</identifier><identifier>PMID: 25100767</identifier><language>eng</language><publisher>England</publisher><subject>Adrenergic beta-Antagonists - pharmacology ; Animals ; Anti-Arrhythmia Agents - pharmacology ; Arrhythmias, Cardiac - genetics ; Arrhythmias, Cardiac - metabolism ; Arrhythmias, Cardiac - physiopathology ; Arrhythmias, Cardiac - prevention & control ; Autonomic Nervous System - drug effects ; Autonomic Nervous System - metabolism ; Autonomic Nervous System - physiopathology ; Calcium Channel Blockers - pharmacology ; Calcium Channels, L-Type - drug effects ; Calcium Channels, L-Type - metabolism ; Calcium Channels, N-Type - drug effects ; Calcium Channels, N-Type - genetics ; Calcium Channels, N-Type - metabolism ; Cardiomyopathy, Dilated - drug therapy ; Cardiomyopathy, Dilated - genetics ; Cardiomyopathy, Dilated - metabolism ; Cardiomyopathy, Dilated - physiopathology ; Death, Sudden, Cardiac - etiology ; Death, Sudden, Cardiac - prevention & control ; Dihydropyridines - pharmacology ; Disease Models, Animal ; Heart - innervation ; Heart Failure - drug therapy ; Heart Failure - genetics ; Heart Failure - metabolism ; Heart Failure - physiopathology ; Mice, Knockout ; Mice, Transgenic ; Nitrendipine - pharmacology ; Repressor Proteins - genetics ; Repressor Proteins - metabolism ; Time Factors ; Ventricular Function, Left - drug effects</subject><ispartof>Cardiovascular research, 2014-10, Vol.104 (1), p.183-193</ispartof><rights>Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2014. For permissions please email: journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c253t-879507e71335f7ae02b325fa42bb7ae162eba9b63a65b049307b0489f2d6d5e73</citedby><cites>FETCH-LOGICAL-c253t-879507e71335f7ae02b325fa42bb7ae162eba9b63a65b049307b0489f2d6d5e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25100767$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamada, Yuko</creatorcontrib><creatorcontrib>Kinoshita, Hideyuki</creatorcontrib><creatorcontrib>Kuwahara, Koichiro</creatorcontrib><creatorcontrib>Nakagawa, Yasuaki</creatorcontrib><creatorcontrib>Kuwabara, Yoshihiro</creatorcontrib><creatorcontrib>Minami, Takeya</creatorcontrib><creatorcontrib>Yamada, Chinatsu</creatorcontrib><creatorcontrib>Shibata, Junko</creatorcontrib><creatorcontrib>Nakao, Kazuhiro</creatorcontrib><creatorcontrib>Cho, Kosai</creatorcontrib><creatorcontrib>Arai, Yuji</creatorcontrib><creatorcontrib>Yasuno, Shinji</creatorcontrib><creatorcontrib>Nishikimi, Toshio</creatorcontrib><creatorcontrib>Ueshima, Kenji</creatorcontrib><creatorcontrib>Kamakura, Shiro</creatorcontrib><creatorcontrib>Nishida, Motohiro</creatorcontrib><creatorcontrib>Kiyonaka, Shigeki</creatorcontrib><creatorcontrib>Mori, Yasuo</creatorcontrib><creatorcontrib>Kimura, Takeshi</creatorcontrib><creatorcontrib>Kangawa, Kenji</creatorcontrib><creatorcontrib>Nakao, Kazuwa</creatorcontrib><title>Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure</title><title>Cardiovascular research</title><addtitle>Cardiovasc Res</addtitle><description>Dysregulation of autonomic nervous system activity can trigger ventricular arrhythmias and sudden death in patients with heart failure. N-type Ca(2+) channels (NCCs) play an important role in sympathetic nervous system activation by regulating the calcium entry that triggers release of neurotransmitters from peripheral sympathetic nerve terminals. We have investigated the ability of NCC blockade to prevent lethal arrhythmias associated with heart failure.
We compared the effects of cilnidipine, a dual N- and L-type Ca(2+) channel blocker, with those of nitrendipine, a selective L-type Ca(2+) channel blocker, in transgenic mice expressing a cardiac-specific, dominant-negative form of neuron-restrictive silencer factor (dnNRSF-Tg). In this mouse model of dilated cardiomyopathy leading to sudden arrhythmic death, cardiac structure and function did not significantly differ among the control, cilnidipine, and nitrendipine groups. However, cilnidipine dramatically reduced arrhythmias in dnNRSF-Tg mice, significantly improving their survival rate and correcting the imbalance between cardiac sympathetic and parasympathetic nervous system activity. A β-blocker, bisoprolol, showed similar effects in these mice. Genetic titration of NCCs, achieved by crossing dnNRSF-Tg mice with mice lacking CACNA1B, which encodes the α1 subunit of NCCs, improved the survival rate. With restoration of cardiac autonomic balance, dnNRSF-Tg;CACNA1B(+/-) mice showed fewer malignant arrhythmias than dnNRSF-Tg;CACNA1B(+/+) mice.
Both pharmacological blockade of NCCs and their genetic titration improved cardiac autonomic balance and prevented lethal arrhythmias in a mouse model of dilated cardiomyopathy and sudden arrhythmic death. Our findings suggest that NCC blockade is a potentially useful approach to preventing sudden death in patients with heart failure.</description><subject>Adrenergic beta-Antagonists - pharmacology</subject><subject>Animals</subject><subject>Anti-Arrhythmia Agents - pharmacology</subject><subject>Arrhythmias, Cardiac - genetics</subject><subject>Arrhythmias, Cardiac - metabolism</subject><subject>Arrhythmias, Cardiac - physiopathology</subject><subject>Arrhythmias, Cardiac - prevention & control</subject><subject>Autonomic Nervous System - drug effects</subject><subject>Autonomic Nervous System - metabolism</subject><subject>Autonomic Nervous System - physiopathology</subject><subject>Calcium Channel Blockers - pharmacology</subject><subject>Calcium Channels, L-Type - drug effects</subject><subject>Calcium Channels, L-Type - metabolism</subject><subject>Calcium Channels, N-Type - drug effects</subject><subject>Calcium Channels, N-Type - genetics</subject><subject>Calcium Channels, N-Type - metabolism</subject><subject>Cardiomyopathy, Dilated - drug therapy</subject><subject>Cardiomyopathy, Dilated - genetics</subject><subject>Cardiomyopathy, Dilated - metabolism</subject><subject>Cardiomyopathy, Dilated - physiopathology</subject><subject>Death, Sudden, Cardiac - etiology</subject><subject>Death, Sudden, Cardiac - prevention & control</subject><subject>Dihydropyridines - pharmacology</subject><subject>Disease Models, Animal</subject><subject>Heart - innervation</subject><subject>Heart Failure - drug therapy</subject><subject>Heart Failure - genetics</subject><subject>Heart Failure - metabolism</subject><subject>Heart Failure - physiopathology</subject><subject>Mice, Knockout</subject><subject>Mice, Transgenic</subject><subject>Nitrendipine - pharmacology</subject><subject>Repressor Proteins - genetics</subject><subject>Repressor Proteins - metabolism</subject><subject>Time Factors</subject><subject>Ventricular Function, Left - drug effects</subject><issn>0008-6363</issn><issn>1755-3245</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNo9UcuO1DAQtBCInV248AGojwgU8GNsJ0c04rHSCi5wjtpORzFKnMF2Bs2v8LV4NcseWtUlVZXUXYy9Evy94J364E-pziZa_YTthNW6UXKvn7Id57xtjDLqil3n_KtSre3-ObuSWnBujd2xv7dxCi6UsEZYR_jWlPOR4IDyHfgJY6Q5Ay40hzVhobpHCIvDGaMnCBE8piGgB9zKGtcleIiUTgToSziFcq6GAY6JThRLhpnKhDNgStO5TEvAfJ9RXQR_QplgIkwFRgzzlugFezbinOnlA96wn58__Th8be6-f7k9fLxrvNSqNK3tNLdkhVJ6tEhcOiX1iHvpXKXCSHLYOaPQaMf3neK2QtuNcjCDJqtu2JtL7jGtvzfKpV9C9jTXG2ndci-0MUJI2ZoqfXuR-rTmnGjsjyksmM694P19F33tor90UcWvH3I3t9DwKP3_fPUPG06IRQ</recordid><startdate>20141001</startdate><enddate>20141001</enddate><creator>Yamada, Yuko</creator><creator>Kinoshita, Hideyuki</creator><creator>Kuwahara, Koichiro</creator><creator>Nakagawa, Yasuaki</creator><creator>Kuwabara, Yoshihiro</creator><creator>Minami, Takeya</creator><creator>Yamada, Chinatsu</creator><creator>Shibata, Junko</creator><creator>Nakao, Kazuhiro</creator><creator>Cho, Kosai</creator><creator>Arai, Yuji</creator><creator>Yasuno, Shinji</creator><creator>Nishikimi, Toshio</creator><creator>Ueshima, Kenji</creator><creator>Kamakura, Shiro</creator><creator>Nishida, Motohiro</creator><creator>Kiyonaka, Shigeki</creator><creator>Mori, Yasuo</creator><creator>Kimura, Takeshi</creator><creator>Kangawa, Kenji</creator><creator>Nakao, Kazuwa</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20141001</creationdate><title>Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure</title><author>Yamada, Yuko ; Kinoshita, Hideyuki ; Kuwahara, Koichiro ; Nakagawa, Yasuaki ; Kuwabara, Yoshihiro ; Minami, Takeya ; Yamada, Chinatsu ; Shibata, Junko ; Nakao, Kazuhiro ; Cho, Kosai ; Arai, Yuji ; Yasuno, Shinji ; Nishikimi, Toshio ; Ueshima, Kenji ; Kamakura, Shiro ; Nishida, Motohiro ; Kiyonaka, Shigeki ; Mori, Yasuo ; Kimura, Takeshi ; Kangawa, Kenji ; Nakao, Kazuwa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c253t-879507e71335f7ae02b325fa42bb7ae162eba9b63a65b049307b0489f2d6d5e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adrenergic beta-Antagonists - pharmacology</topic><topic>Animals</topic><topic>Anti-Arrhythmia Agents - pharmacology</topic><topic>Arrhythmias, Cardiac - genetics</topic><topic>Arrhythmias, Cardiac - metabolism</topic><topic>Arrhythmias, Cardiac - physiopathology</topic><topic>Arrhythmias, Cardiac - prevention & control</topic><topic>Autonomic Nervous System - drug effects</topic><topic>Autonomic Nervous System - metabolism</topic><topic>Autonomic Nervous System - physiopathology</topic><topic>Calcium Channel Blockers - pharmacology</topic><topic>Calcium Channels, L-Type - drug effects</topic><topic>Calcium Channels, L-Type - metabolism</topic><topic>Calcium Channels, N-Type - drug effects</topic><topic>Calcium Channels, N-Type - genetics</topic><topic>Calcium Channels, N-Type - metabolism</topic><topic>Cardiomyopathy, Dilated - drug therapy</topic><topic>Cardiomyopathy, Dilated - genetics</topic><topic>Cardiomyopathy, Dilated - metabolism</topic><topic>Cardiomyopathy, Dilated - physiopathology</topic><topic>Death, Sudden, Cardiac - etiology</topic><topic>Death, Sudden, Cardiac - prevention & control</topic><topic>Dihydropyridines - pharmacology</topic><topic>Disease Models, Animal</topic><topic>Heart - innervation</topic><topic>Heart Failure - drug therapy</topic><topic>Heart Failure - genetics</topic><topic>Heart Failure - metabolism</topic><topic>Heart Failure - physiopathology</topic><topic>Mice, Knockout</topic><topic>Mice, Transgenic</topic><topic>Nitrendipine - pharmacology</topic><topic>Repressor Proteins - genetics</topic><topic>Repressor Proteins - metabolism</topic><topic>Time Factors</topic><topic>Ventricular Function, Left - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamada, Yuko</creatorcontrib><creatorcontrib>Kinoshita, Hideyuki</creatorcontrib><creatorcontrib>Kuwahara, Koichiro</creatorcontrib><creatorcontrib>Nakagawa, Yasuaki</creatorcontrib><creatorcontrib>Kuwabara, Yoshihiro</creatorcontrib><creatorcontrib>Minami, Takeya</creatorcontrib><creatorcontrib>Yamada, Chinatsu</creatorcontrib><creatorcontrib>Shibata, Junko</creatorcontrib><creatorcontrib>Nakao, Kazuhiro</creatorcontrib><creatorcontrib>Cho, Kosai</creatorcontrib><creatorcontrib>Arai, Yuji</creatorcontrib><creatorcontrib>Yasuno, Shinji</creatorcontrib><creatorcontrib>Nishikimi, Toshio</creatorcontrib><creatorcontrib>Ueshima, Kenji</creatorcontrib><creatorcontrib>Kamakura, Shiro</creatorcontrib><creatorcontrib>Nishida, Motohiro</creatorcontrib><creatorcontrib>Kiyonaka, Shigeki</creatorcontrib><creatorcontrib>Mori, Yasuo</creatorcontrib><creatorcontrib>Kimura, Takeshi</creatorcontrib><creatorcontrib>Kangawa, Kenji</creatorcontrib><creatorcontrib>Nakao, Kazuwa</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamada, Yuko</au><au>Kinoshita, Hideyuki</au><au>Kuwahara, Koichiro</au><au>Nakagawa, Yasuaki</au><au>Kuwabara, Yoshihiro</au><au>Minami, Takeya</au><au>Yamada, Chinatsu</au><au>Shibata, Junko</au><au>Nakao, Kazuhiro</au><au>Cho, Kosai</au><au>Arai, Yuji</au><au>Yasuno, Shinji</au><au>Nishikimi, Toshio</au><au>Ueshima, Kenji</au><au>Kamakura, Shiro</au><au>Nishida, Motohiro</au><au>Kiyonaka, Shigeki</au><au>Mori, Yasuo</au><au>Kimura, Takeshi</au><au>Kangawa, Kenji</au><au>Nakao, Kazuwa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure</atitle><jtitle>Cardiovascular research</jtitle><addtitle>Cardiovasc Res</addtitle><date>2014-10-01</date><risdate>2014</risdate><volume>104</volume><issue>1</issue><spage>183</spage><epage>193</epage><pages>183-193</pages><issn>0008-6363</issn><eissn>1755-3245</eissn><abstract>Dysregulation of autonomic nervous system activity can trigger ventricular arrhythmias and sudden death in patients with heart failure. N-type Ca(2+) channels (NCCs) play an important role in sympathetic nervous system activation by regulating the calcium entry that triggers release of neurotransmitters from peripheral sympathetic nerve terminals. We have investigated the ability of NCC blockade to prevent lethal arrhythmias associated with heart failure.
We compared the effects of cilnidipine, a dual N- and L-type Ca(2+) channel blocker, with those of nitrendipine, a selective L-type Ca(2+) channel blocker, in transgenic mice expressing a cardiac-specific, dominant-negative form of neuron-restrictive silencer factor (dnNRSF-Tg). In this mouse model of dilated cardiomyopathy leading to sudden arrhythmic death, cardiac structure and function did not significantly differ among the control, cilnidipine, and nitrendipine groups. However, cilnidipine dramatically reduced arrhythmias in dnNRSF-Tg mice, significantly improving their survival rate and correcting the imbalance between cardiac sympathetic and parasympathetic nervous system activity. A β-blocker, bisoprolol, showed similar effects in these mice. Genetic titration of NCCs, achieved by crossing dnNRSF-Tg mice with mice lacking CACNA1B, which encodes the α1 subunit of NCCs, improved the survival rate. With restoration of cardiac autonomic balance, dnNRSF-Tg;CACNA1B(+/-) mice showed fewer malignant arrhythmias than dnNRSF-Tg;CACNA1B(+/+) mice.
Both pharmacological blockade of NCCs and their genetic titration improved cardiac autonomic balance and prevented lethal arrhythmias in a mouse model of dilated cardiomyopathy and sudden arrhythmic death. Our findings suggest that NCC blockade is a potentially useful approach to preventing sudden death in patients with heart failure.</abstract><cop>England</cop><pmid>25100767</pmid><doi>10.1093/cvr/cvu185</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-6363 |
ispartof | Cardiovascular research, 2014-10, Vol.104 (1), p.183-193 |
issn | 0008-6363 1755-3245 |
language | eng |
recordid | cdi_proquest_miscellaneous_1566112286 |
source | Oxford Journals Online |
subjects | Adrenergic beta-Antagonists - pharmacology Animals Anti-Arrhythmia Agents - pharmacology Arrhythmias, Cardiac - genetics Arrhythmias, Cardiac - metabolism Arrhythmias, Cardiac - physiopathology Arrhythmias, Cardiac - prevention & control Autonomic Nervous System - drug effects Autonomic Nervous System - metabolism Autonomic Nervous System - physiopathology Calcium Channel Blockers - pharmacology Calcium Channels, L-Type - drug effects Calcium Channels, L-Type - metabolism Calcium Channels, N-Type - drug effects Calcium Channels, N-Type - genetics Calcium Channels, N-Type - metabolism Cardiomyopathy, Dilated - drug therapy Cardiomyopathy, Dilated - genetics Cardiomyopathy, Dilated - metabolism Cardiomyopathy, Dilated - physiopathology Death, Sudden, Cardiac - etiology Death, Sudden, Cardiac - prevention & control Dihydropyridines - pharmacology Disease Models, Animal Heart - innervation Heart Failure - drug therapy Heart Failure - genetics Heart Failure - metabolism Heart Failure - physiopathology Mice, Knockout Mice, Transgenic Nitrendipine - pharmacology Repressor Proteins - genetics Repressor Proteins - metabolism Time Factors Ventricular Function, Left - drug effects |
title | Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T04%3A42%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20N-type%20Ca2+%20channels%20ameliorates%20an%20imbalance%20in%20cardiac%20autonomic%20nerve%20activity%20and%20prevents%20lethal%20arrhythmias%20in%20mice%20with%20heart%20failure&rft.jtitle=Cardiovascular%20research&rft.au=Yamada,%20Yuko&rft.date=2014-10-01&rft.volume=104&rft.issue=1&rft.spage=183&rft.epage=193&rft.pages=183-193&rft.issn=0008-6363&rft.eissn=1755-3245&rft_id=info:doi/10.1093/cvr/cvu185&rft_dat=%3Cproquest_cross%3E1566112286%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c253t-879507e71335f7ae02b325fa42bb7ae162eba9b63a65b049307b0489f2d6d5e73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1566112286&rft_id=info:pmid/25100767&rfr_iscdi=true |